Stock A328130 LUNIT INC.
Add to a list
To use this feature you must be a member
Log inSign up

Lunit Inc.

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 14/06/2024 am IST 		5-day change 1st Jan Change
50,400 KRW -0.79% Intraday chart for Lunit Inc. -4.18% -38.46%
31/05 Lunit Inc. announced that it has received KRW 171.5 billion in funding from a group of investors CI
24/05 Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Lunit Inc.

Lunit Inc. announced that it has received KRW 171.5 billion in funding from a group of investors CI
Lunit to Showcase 7 Studies at Asco 2024, Including Ai Innovations in Her2 Quantification, and Multimodal Predictive Models for Immunotherapy Response CI
Lunit Acquires New Zealand's Volpara Health Technologies MT
Lunit Inc. completed the acquisition of Volpara Health Technologies Limited from Harbour Asset Management Limited and others. CI
Volpara to Delist After Court Approves Acquisition by Lunit MT
Lunit Wins Shareholder Approval for Volpara Health Takeover MT
Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover MT
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals CI
Lunit Announces Publication of New Study Featuring Lunit SCOPE IO CI
Lunit Announces Two Commercial Deals Signal its Expansion in Europe CI
Lunit Inc. Receives Two Supply Contracts That Mark Its Strategic Expansion into the East and Southeast Asian Region CI
Lunit Announces Three-Year Supply Contract with Samsung Electronics CI
GC Cell Signs Agreement with Lunit for AI-Powered Cancer Treatment MT
Lunit to Take Over Volpara Health; Lunit Shares Decline 4% MT
Lunit Inc. agreed to acquire Volpara Health Technologies Limited from Harbour Asset Management Limited and others for AUD 300 million. CI
Lunit Inc. Partners with NTT DATA Singapore to Introduce Lunit Insight CXR to Singapore's Public Healthcare System CI
Lunit Unveils Prognostic Insights for Colon Cancer - Published in Npj Precision Oncology CI
Lunit Announces to Unveil Eight Groundbreaking Abstracts At the Radiological Society of North America CI
Lunit Inc. Receives U.S. Food and Drug Administration 510(K) Clearance for its 3D Breast Tomosynthesis Ai Solution, Lunit Insight DBT CI
Lunit Expands Reach of Its AI-Powered Chest Screening Solution to Global Military Health Institutions CI
Lunit Inc. Announces Collaborative Study with the Samsung Medical Center Assessed Tumor-Infiltrating Lymphocytes CI
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy CI
New Study Demonstrates Lunit Inc. Scope Io's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to Be Presented At the ESMO 2023 CI
Lunit Presents Study on Predicting Treatment Response by HER2 Analysis in Colorectal Cancer CI
Blackford and Lunit Inc Announce Partnership to Enhance Chest and Breast Ai Solution Offering CI

Chart Lunit Inc.

Chart Lunit Inc.
More charts

Company Profile

Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.
Sector
Advanced Medical Equipment & Technology
Calendar
11/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Lunit Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
50,400 KRW
Average target price
1,00,000 KRW
Spread / Average Target
+98.41%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
LUNIT INC. Stock Lunit Inc.
-38.46% 1.05B
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-4.06% 29.86B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+36.88% 9.06B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-34.39% 2.49B
VERADIGM INC. Stock Veradigm Inc.
-14.11% 1.52B
OMNICELL, INC. Stock Omnicell, Inc.
-25.83% 1.28B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+4.27% 932M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-41.98% 809M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-25.42% 659M
ENTERO HEALTHCARE SOLUTIONS LIMITED Stock Entero Healthcare Solutions Limited
0.00% 535M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. A328130 Stock
  4. News Lunit Inc.
  5. Lunit Acquires New Zealand's Volpara Health Technologies